UA37857U - Method for predicting threatening miscarriage in the first trimester in patients with fibrocystic disease of breast - Google Patents

Method for predicting threatening miscarriage in the first trimester in patients with fibrocystic disease of breast

Info

Publication number
UA37857U
UA37857U UAU200809183U UAU200809183U UA37857U UA 37857 U UA37857 U UA 37857U UA U200809183 U UAU200809183 U UA U200809183U UA U200809183 U UAU200809183 U UA U200809183U UA 37857 U UA37857 U UA 37857U
Authority
UA
Ukraine
Prior art keywords
trimester
predicting
patients
breast
fibrocystic disease
Prior art date
Application number
UAU200809183U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ирина Анатольевна Жабченко
Зинаида Борисовна Хоминская
Антонина Георгиевна Коломийцева
Людмила Васильевна Диденко
Елена Николаевна Бондаренко
Наталья Яковлевна Скрипченко
Ольга Ивановна Буткова
Анна Евгеньевна Яремко
Таисия Степановна Черненко
Тамара Николаевна Коваленко
Original Assignee
Государственное Учреждение "Институт Педиатрии, Акушерства И Гинекологии Амн Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Педиатрии, Акушерства И Гинекологии Амн Украины" filed Critical Государственное Учреждение "Институт Педиатрии, Акушерства И Гинекологии Амн Украины"
Priority to UAU200809183U priority Critical patent/UA37857U/en
Publication of UA37857U publication Critical patent/UA37857U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method for predicting the threatening miscarriage in the first trimester in the patients with fibrocystic disease of the breast provides for assaying the hormonal parameters. The serum content of prolactin and melatonin is assayed. The increase in prolactin content by 250% and the decrease in melatonin content by 35% relative to the normal values are of prognostic value.
UAU200809183U 2008-07-14 2008-07-14 Method for predicting threatening miscarriage in the first trimester in patients with fibrocystic disease of breast UA37857U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200809183U UA37857U (en) 2008-07-14 2008-07-14 Method for predicting threatening miscarriage in the first trimester in patients with fibrocystic disease of breast

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200809183U UA37857U (en) 2008-07-14 2008-07-14 Method for predicting threatening miscarriage in the first trimester in patients with fibrocystic disease of breast

Publications (1)

Publication Number Publication Date
UA37857U true UA37857U (en) 2008-12-10

Family

ID=50554457

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200809183U UA37857U (en) 2008-07-14 2008-07-14 Method for predicting threatening miscarriage in the first trimester in patients with fibrocystic disease of breast

Country Status (1)

Country Link
UA (1) UA37857U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2469331C1 (en) * 2011-08-18 2012-12-10 Федеральное государственное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения и социального развития Российской Федерации Method for prediction of threatened miscarriage in 1 trimester

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2469331C1 (en) * 2011-08-18 2012-12-10 Федеральное государственное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения и социального развития Российской Федерации Method for prediction of threatened miscarriage in 1 trimester

Similar Documents

Publication Publication Date Title
NZ607282A (en) Method for using gene expression to determine prognosis of prostate cancer
IN2014CN02483A (en)
GB201120552D0 (en) Method and system for integrated analysis
NZ614566A (en) Methods and systems for assessing clinical outcomes
WO2012076553A3 (en) Biomarkers and parameters for hypertensive disorders of pregnancy
WO2011080130A3 (en) In situ detoxification of fermentation inhibitors with reducing agents
WO2010135574A3 (en) Systems and methods for determining the percentage of glycated hemoglobin
IN2013DN02527A (en)
IN2015DN00678A (en)
MX347788B (en) Diagnosis and treatment of preeclampsia.
WO2005123945A3 (en) Epigenetic markers for the treatment of breast cancer
WO2010092190A3 (en) Prediction of response to platinum-based therapy
PL2185937T3 (en) Method for assaying sepsis in humans
PH12014502410A1 (en) Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression
MX2009011494A (en) Disease markers.
WO2011133036A3 (en) Means and methods for determining risk of cardiovascular disease
UA37857U (en) Method for predicting threatening miscarriage in the first trimester in patients with fibrocystic disease of breast
SG171495A1 (en) Methods and systems for consuming media content among a group of at least two entities
GB2462218A (en) Subject modelling
EP2551747A3 (en) Power saving method and touch display apparatus
MX2010006890A (en) Method for predicting responsiveness to a pharmaceutical therapy for obesity.
UA53577U (en) Method for predicting course of early terms of gestation
UA46138U (en) Method for assessing hypobiosis hazard
UA64044U (en) Method for predicting hypogalactia in patients with fibrocystic disease of breast
GB201204013D0 (en) Method